Biomechanical properties measured with dynamic Scheimpflug analyzer in central serous chorioretinopathy
Graefe's Archive for Clinical and Experimental Ophthalmology · 2024
DOI: 10.1007/s00417-024-06378-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Graefe's Archive for Clinical and Experimental Ophthalmology, 2024. Verfasst von Shuichiro Aoki und 6 weiteren Autor:innen. Beteiligte Einrichtung: The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan. aokis-oph@h.u-tokyo.ac.jp. Hauptthemen laut MEDLINE: Central Serous Chorioretinopathy, Tomography, Optical Coherence, Cornea. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, the Ministry of Education, Culture, Sports, Science and Technology of Japan, The University of Tokyo.
Abstract (Originalsprache)
Purpose
Recent evidence suggests that venous congestion at the vortex vein significantly contributes to the development of central serous chorioretinopathy (CSCR), and sclera is observed to be thicker in affected eyes. This study aims to investigate whether eyes with CSCR exhibit stiff corneas, measured using Corneal Visualization Scheimflug Technology (Corvis ST), which may serve as an indicator of scleral stiffness.
Methods
This retrospective case–control study comprises 52 eyes from 33 patients diagnosed with CSCR and 52 eyes from 32 normal controls without CSCR. We compared biomechanical parameters measured with Corvis ST and anterior scleral thickness measured using anterior segment swept-source optical coherence tomography between the two groups.
Results
Age, sex, axial length, intraocular pressure, and central corneal thickness showed no significant differences between the two groups ( p > 0.05, linear mixed model). Three biomechanical parameters—peak distance, maximum deflection amplitude, and integrated inverse radius—indicated less deformability in CSCR eyes compared to control eyes. The stress–strain index (SSI), a measure of stiffness, and anterior scleral thickness (AST) at temporal and nasal points were significantly higher in the CSCR eyes. SSI and AST were not correlated, yet both were significantly and independently associated with CSCR in a multivariate logistic regression model.
Conclusions
Eyes affected by CSCR have stiffer corneas, irrespective of thicker scleral thickness. This suggests that stiffer sclera may play a role in the pathogenesis of CSCR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan. aokis-oph@h.u-tokyo.ac.jp.
- Seirei Christopher University, Hamamatsu, Japan.
- The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan.
- Yokohama City University, Yokohama, Japan.
Förderung
- Ministry of Education, Culture, Sports, Science and Technology
- the Ministry of Education, Culture, Sports, Science and Technology of Japan
- The University of Tokyo
Zitieren
APA
Aoki, S., Asaoka, R., Azuma, K., Kitamoto, K., Ueda, K., Inoue, T., & Obata, R. (2024). Biomechanical properties measured with dynamic Scheimpflug analyzer in central serous chorioretinopathy. Graefe's Archive for Clinical and Experimental Ophthalmology. https://doi.org/10.1007/s00417-024-06378-0
Vancouver
Aoki S, Asaoka R, Azuma K, Kitamoto K, Ueda K, Inoue T, et al. Biomechanical properties measured with dynamic Scheimpflug analyzer in central serous chorioretinopathy. Graefe's Archive for Clinical and Experimental Ophthalmology. 2024. doi:10.1007/s00417-024-06378-0
BibTeX
@article{Aoki2024,
author = {Aoki, Shuichiro and Asaoka, Ryo and Azuma, Keiko and Kitamoto, Kohdai and Ueda, Kohei and Inoue, Tatsuya and Obata, Ryo},
title = {Biomechanical properties measured with dynamic Scheimpflug analyzer in central serous chorioretinopathy},
journal = {Graefe's Archive for Clinical and Experimental Ophthalmology},
year = {2024},
doi = {10.1007/s00417-024-06378-0}
}
EUVIMED